Endo announced Thursday that regulatory waiting periods in the United States and Canada related to its plans to acquire a Montreal-based drug maker have been terminated.
Endo Health Solutions will acquire Canadian drug maker Paladin Labs for $1.6 billion, mostly in shares of stock, Endo said Tuesday.
A subsidiary of Endo Health Solutions is buying Boca Pharmacal for $225 million, Endo said Wednesday.
The parent company of Endo Pharmaceuticals has changed its name, the company said.
Endo's parent company is looking to change its name and will integrate four of its operating units, the drug maker said Thursday.
The Food and Drug Administration has approved a new formulation of a painkiller made by Endo Pharmaceuticals designed to thwart drug abuse, Endo said Monday.
Profits for Endo Pharmaceutical Holdings rose to $54.6 million during second quarter 2011, up 6% from $51.5 million in second quarter 2010, the drug maker said.
The Food and Drug Administration has accepted a resubmission by Endo Pharmaceuticals of a regulatory application for an opioid pain drug designed to thwart abuse, Endo said.
Endo Pharmaceuticals has acquired a provider of devices and therapies for male and female pelvic health.
Endo Pharmaceuticals will buy American Medical Systems for $2.9 billion, the drug maker said Monday.
Endo's board of directors has expanded to nine members with the addition of David Nash.
Endo Pharmaceuticals has launched a recently approved testosterone gel for men.
The Food and Drug Administration has approved a topical testosterone replacement therapy made by Endo Pharmaceuticals, Endo said last week.
Endo Pharmaceuticals has finished its acquisition of Qualitest Pharmaceuticals for $1.2 billion, Endo said Wednesday.
Strong generic sales helped Endo edge analyst expectations for the third quarter, the company noted....
Watson Pharmaceuticals has settled a patent lawsuit with Endo Pharmaceuticals concerning an Endo prescription painkiller,...
Endo Pharmaceuticals will acquire generic drug maker Qualitest Pharmaceuticals for $1.2 billion, Endo said Tuesday....
Endo Pharmaceuticals will acquire Penwest Pharmaceuticals for $168 million, Penwest said Monday....
Endo Pharmaceuticals has completed its acquisition of a company that provides urological products and services,...
Endo Pharmaceuticals and Penwest Pharmaceuticals will grant Impax Labs a special license to sell a...